Últimos Artículos de Terapeuthic Advances in Endocrinology and Metabolism
- Analysis of composite immune-inflam matory indices using interpretable machine learning for identifying prevalent metabolic dysfunction-associated steatotic liver disease in patients with diabetes
- TRAb-negative euthyroid thyroid eye disease: A case report and literature review
- Oxidative stress in diabetic peripheral neuropathies: Key mechanisms and therapeutic targets
- A rare presentation of RET mutation: Early-onset medullary thyroid carcinoma with intestinal neuronal dysplasia and chronic kidney disease, A case report and literature review
- Perceptions of mobile applications and websites for diabetes management among adults with type 2 diabetes in Jordan: A qualitative study
- Metabolic syndrome and hormonal correlates of its predominant components among postmenopausal women: An institution-based cross-sectional study
- Cardiovascular promise requires endpoint discipline: interpreting tirzepatide after SURPASS-CVOT
- Erratum to “Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome”
- Serum testosterone and uric acid: Key biomarkers for predicting response to drospirenone/ethinyl estradiol tablets (II) in adolescents polycystic ovary syndrome
- Author’s reply to the letter to the editor by Yongzhang Qin and Shihua Hong, “Unrecognized primary aldosteronism may confound outcomes in adrenal Cushing’s syndrome”
- Impact of training type (virtual vs in-person) on long-term glycemic control in people with type 1 diabetes using minimed 780: A non-inferiority longitudinal study
- Metabolic effects of GLP-1 and GLP-2 across fed, fasting, and starvation states: A systematic review with structured narrative synthesis
- Systematic review and network meta-analysis of the safety and efficacy of the triple incretin receptor agonist, retatrutide compared to the dual incretin receptor agonist, tirzepatide, for treatment of type 2 diabetes mellitus
- The uric acid-to-homocysteine ratio as a prognostic marker for all-cause and cardiovascular mortality: A national population-based study
- Associations of mortality and sepsis after GLP-1 receptor agonist initiation versus SGLT2 inhibitor or metformin initiation in people with HIV, overweight or obesity, and type 2 diabetes: A target trial emulation
- Dietary protein content and its impact on amino acid profile and appetite in patients with methylmalonic acidemia
- Hashimoto’s thyroiditis and ablation-zone involution after microwave ablation for low-risk papillary thyroid carcinoma: An overlap-weighted cohort study
- Association between the ratio of uric acid to high-density lipoprotein cholesterol (UHR) and the abnormal risk of sarcopenia: Evidence from two large population-based surveys and interpretable machine learning-driven sarcopenia screening
- Association between HOMA-IR and coexisting MASLD and type 2 diabetes: Insights from NHANES and network pharmacology
- Association between glycerol triglyceride glucose-related index and cardiovascular disease in individuals with metabolic dysfunction-associated steatotic liver disease: NHANES 1999–2023